论文部分内容阅读
目的 探讨体外受精-胚胎移植(IVF-ET)治疗子宫内膜非典型增生合并不孕症患者的有效性和安全性.方法 回顾性分析2013年1月至2015年12月期间因不孕症来我院生殖医学科就诊的1 0例子宫内膜非典型增生,经妇科规范治疗完全缓解后的患者,对于其IVF-ET治疗的各临床数据进行分析.结果 9例患者共行IVF-ET术10次,妊娠4例,妊娠率40％.术后半年后病变复发0例,一年至两年复发2例,复发率25％.结论 不孕症合并子宫内膜非典型增生患者治疗缓解后,及时行IVF-ET治疗可以提高妊娠率,目前没有证据支持IVF治疗会增加子宫内膜病变复发的风险.“,”Objective:To explore the efficacy and safety of in vitro fertilization and embryo transfer (IVF-ET) in patients with atypical hyperplasia of infertility with endometriosis.Methods:The clinical,imaging and laboratory data of 10 cases were analyzed,who were sterile and treated by IVF-ET in our hospital reproductive medicine department after endometrial atypical hyperplasia complete remission during January 2013 to December 2015.Results:9 patients suffered IVF-ET surgery 10 times,4 cases of pregnancy,pregnancy rate of 40％.No recurrence after six months.Recurrence of one year to two years was 2 cases.The recurrence rate was 25％.Conclusion:Treatment timely of IVF-ET can improve the pregnancy rate for the patients atypical hyperplasia with infertility,there is no evidence to support IVF treatment will increase the risk of recurrence of endometrial lesions.